A Comparative Analysis of Biotechnology Startups between Japan and the US
AbstractIn this paper, I compare activities in biotech firms in the two countries based on firm-level data in 2004 (443 Japanese firms, 12 of which are listed publicly, and 1,446 US firms, 431 of which are public). First, I found that Japanese firms are much smaller than US firms, even after controlling for firm age and technology field. Furthermore, Japanese firms grow over time, while the size of US firms does not change. These findings suggestthat there are some differences in the biotech business models of the two countries. I also found that US firms spend a large amount of R&D particularly in the areas of medical and health, while Japanese firms do not. Therefore, most Japanese firms do not invest a substantial amount of R&D in risky areas but run businesses in low-risk areas, such as providing R&D services. I argue that such differences in startup activities can be explained by differences in the venture capital markets between Japan and the US.
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoPaper provided by University Library of Munich, Germany in its series MPRA Paper with number 50095.
Date of creation: Jul 2012
Date of revision:
Publication status: Published in Social Science Japan Journal 2.15(2012): pp. 219-237
Biotech firms; Japan; US; international comparison; venture capital;
Find related papers by JEL classification:
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology
- M13 - Business Administration and Business Economics; Marketing; Accounting - - Business Administration - - - New Firms; Startups
- O32 - Economic Development, Technological Change, and Growth - - Technological Change; Research and Development; Intellectual Property Rights - - - Management of Technological Innovation and R&D
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Lynne G. Zucker & Michael R. Darby, 1998.
"Capturing Technological Opportunity via Japan's Star Scientists: Evidence from Japanese Firms' Biotech Patents and Products,"
NBER Working Papers
6360, National Bureau of Economic Research, Inc.
- Zucker, Lynne G & Darby, Michael R, 2001. " Capturing Technological Opportunity via Japan's Star Scientists: Evidence from Japanese Firms' Biotech Patents and Products," The Journal of Technology Transfer, Springer, vol. 26(1-2), pages 37-58, January.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Ekkehart Schlicht).
If references are entirely missing, you can add them using this form.